Home | All trials

[RDF data]
Trial NCT00000323

Resource URI: http://static.linkedct.org/resource/trials/NCT00000323
PropertyValue
linkedct:brief_title Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Inclusion Criteria: opiate experienced, healthy Exclusion Criteria: physical dependence on opioids, barbiturates or alcohol
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers Accepts Healthy Volunteers
linkedct:eligibility_maximum_age 50 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:end_date December 1998
linkedct:enrollment 10 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000323
rdfs:label Trial NCT00000323
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/163316>
linkedct:nct_id NCT00000323
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Therapeutic Potential of Kappa-Opioids Against Cocaine
linkedct:org_study_id NIDA-10753-1
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/54004>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000323>
linkedct:phase Phase 1
linkedct:secondary_id R01-10753-1
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date July 1996
linkedct:study_design Screening
linkedct:study_type Observational
linkedct:summary The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.
rdf:type linkedct:trials
linkedct:verification_date May 2004